>
The Real Cost of Supporting the Zionist Secular State of Israel
Treasury Yield 30 Years (^TYX)
Apoplectic Netanyahu rages at Trump in private as 'disastrous' Iran deal leaves him longing.
The American Consumer Is Piss Broke
Elon and SpaceX Have Made AI Training 10 Times Faster
Oklo COO Says Nuclear Waste Could Power America For 150 Years
SpaceX Announces LARGEST Starship Mission Ever! They've never done this before!
Cars Are Fast Becoming Dystopian Prison Pods...
Our Emergency Water Plan Wasn't Good Enough - So We Built This
Sodium Ion Batteries Can Reach 100 Gigawatt Per Hour Per Year Scale in 2027
Juiced Bikes proves capable electric motorcycles don't have to cost a lot
Headlight projectors turn your car into a drive-in theater
US To Develop Small Modular Nuclear Reactors For Commercial Shipping
New York Mandates Kill Switch and Surveillance Software in Your 3D Printer ...

The Department of Health and Human Services report, which is expected to be published this month, will raise "low folate levels and acetaminophen during pregnancy" as possible causes of autism, people familiar with the matter told the Wall Street Journal.
The review will also highlight folinic acid, known as leucovorin, as a possible therapy to ease autism symptoms in some patients, sources told the Journal.
Autism affected about one in 31 8-year-olds in the US in 2022, according to federal estimates.
Tylenol, manufactured by McNeil Consumer Healthcare, a Kenvue subsidiary, is one of the most widely used over-the-counter painkillers — including among pregnant women.
Its active ingredient, acetaminophen, has been studied for decades.
Some research has suggested risks to fetal development, but other studies found no such link.
"We are using gold-standard science to get to the bottom of America's unprecedented rise in autism rates," an HHS spokesperson told The Post Friday.
"Until we release the final report, any claims about its contents are nothing more than speculation."
The Post has sought comment from Kenvue.
Shares of Kenvue plummeted by 16% after the Journal initially published its story during the course of trading on Wall Street on Friday afternoon — though the stock recovered somewhat near the closing bell.
The American College of Obstetricians and Gynecologists continues to say Tylenol is safe for pregnant women, though it advises all expectant mothers to consult doctors before taking any medication.
Kennedy's report will review existing scientific literature, not a new clinical study, sources told the Journal.
Researchers have long cautioned that pinpointing autism's causes takes years of rigorous work, with genetic factors already proven to play a major role.
"Nothing is more important to us than the health and safety of the people who use our products," a Kenvue spokeswoman told the WSJ.
"We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism."
The looming report could go beyond Tylenol, sources told the Journal, by listing other possible causes of autism and calling for more research.
It is not yet clear whether vaccines — the longtime target of Kennedy's skepticism — will be included.